2-MPPA

Modify Date: 2024-01-11 12:46:43

2-MPPA Structure
2-MPPA structure
Common Name 2-MPPA
CAS Number 254737-29-6 Molecular Weight 206.25900
Density N/A Boiling Point N/A
Molecular Formula C8H14O4S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 2-MPPA


2-MPPA (GPI-5693) is an orally active and selective glutamate carboxypeptidase II (GCP II; PSMA) inhibitor with an IC50 of 90 nM[1][2].

 Names

Name 2-(3-sulfanylpropyl)pentanedioic acid
Synonym More Synonyms

 2-MPPA Biological Activity

Description 2-MPPA (GPI-5693) is an orally active and selective glutamate carboxypeptidase II (GCP II; PSMA) inhibitor with an IC50 of 90 nM[1][2].
Related Catalog
Target

IC50: 90 nM (GCP II)[2]

In Vivo 2-MPPA (10, 30 or 100 mg/kg) significantly attenuates Dizocilpine (HY-15084B) (0.1 mg/kg)-induced prepulse inhibition (PPI) deficits in mice, in a dose dependent manner. The efficacy of 2-MPPA on dizocilpine-induced PPI deficits is significantly antagonized by pretreatment with the selective group II metabotropic glutamate receptor (mGluR) antagonist LY341495 (HY-70059) (1.0 mg/kg)[1]. 2-MPPA (30 mg/kg) significantly prevents the deficit in SNCV induced by both 5 and 25 mg/kg taxol by 96.3 ± 4.4% and 98.3± 11.6% respectively[2]. 2-MPPA (10 mg/kg) inhibits tumor growth in the high expressor PSMA model CWR22RS by 70%[2].
References

[1]. Takatsu Y, et al. Orally active glutamate carboxypeptidase II inhibitor 2-MPPA attenuates dizocilpine-induced prepulse inhibition deficits in mice. Brain Res. 2011 Jan 31;1371:82-6.

[2]. She Y, et al. 2-MPPA, a selective inhibitor of PSMA, delays prostate cancer growth and attenuates taxol-induced neuropathy in mice. Journal of Clinical Oncology, 2005, 23(16_suppl): 8054-8054.

 Chemical & Physical Properties

Molecular Formula C8H14O4S
Molecular Weight 206.25900
Exact Mass 206.06100
PSA 113.40000
LogP 1.26200

 Precursor & DownStream

Precursor  1

DownStream  0

 Synonyms

2-(3-mercaptopropyl)pentanedioic acid
2-MPPA
Pentanedioic acid,2-(3-mercaptopropyl)